◆
Triple receptor action targets GLP-1, GIP, and glucagon simultaneously for unmatched metabolic control.
FREE SHIPPING ON ORDERS OVER $100
Dose ranges reflect commonly studied amounts in published research models. This is not medical advice. For research use only. Not for human consumption.
Protocol Comparison
Metabolic · Body Recomposition
Research dose range
Standard research range
0.5 - 2 mg
Most frequently referenced range across published metabolic research. Primary reference point for GLP-1/GIP/glucagon triple-agonist studies.
Research focus
Metabolic remodeling
Observed window
8-12 weeks
Administration
Once weekly
Primary pathway
GLP-1 / GIP / Glucagon
Research conducted in rodent and primate models. Human research data limited. All figures are for reference only.
PROTOCOL BENEFITS
◆
Triple receptor action targets GLP-1, GIP, and glucagon simultaneously for unmatched metabolic control.
◆
Rewrites your metabolic blueprint with fat loss, muscle preservation, and appetite regulation in one protocol.
◆
Research shows significant reduction in body weight and visceral fat across study models.
SCIENCE
Retatrutide is a triple agonist peptide, activating GLP-1, GIP, and glucagon receptors at once. Most metabolic peptides target one. Retatrutide targets all three simultaneously.
Unlike compounds that only suppress appetite, Retatrutide works at the hormonal level to mobilize fat stores, preserve lean tissue, and recalibrate metabolic set points.
WHAT TO EXPECT
Results are progressive. Most research models show measurable metabolic changes within 4-6 weeks, with significant body composition shifts at 8-12 weeks.
PROTOCOL NOTE
Available in 10mg and 20mg. For research use only. Full usage documentation included with every order.
FAQ
Retatrutide is positioned around simultaneous GLP-1, GIP, and glucagon receptor activity, giving the protocol a broader metabolic research profile.
Most research models show measurable metabolic changes within 4-6 weeks, with larger body composition changes developing around 8-12 weeks.
RELATED PRODUCTS